Circulating tumor DNA (ctDNA) dynamics and survival outcomes in patients (pts) with advanced non-small cell lung cancer (aNSCLC) and high (>50%) programmed cell death-ligand 1 (PD-L1) expression, randomized to cemiplimab (cemi) vs chemotherapy (chemo)

Basit Öğe Kaydı
dc.authoridBondarenko, Igor/0000-0002-6428-8651
dc.authoridBondarenko, Igor/0000-0002-7071-2471
dc.authorwosidBondarenko, Igor/V-2431-2019
dc.authorwosidBondarenko, Igor/U-5156-2017
dc.contributor.authorVokes, Natalie I.
dc.contributor.authorGandara, David R.
dc.contributor.authorSezer, Ahmet
dc.contributor.authorKilickap, Saadettin
dc.contributor.authorGumus, Mahmut
dc.contributor.authorBondarenko, Igor
dc.contributor.authorOzguroglu, Mustafa
dc.date.accessioned2024-05-19T14:51:35Z
dc.date.available2024-05-19T14:51:35Z
dc.date.issued2023
dc.departmentİstinye Üniversitesien_US
dc.descriptionAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- JUN 02-06, 2023 -- Chicago, ILen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipAmer Soc Clin Oncolen_US
dc.description.sponsorshipRegeneron Pharmaceuticals, Inc.; Sanofien_US
dc.description.sponsorshipRegeneron Pharmaceuticals, Inc. and Sanofi.en_US
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue16en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12713/5974
dc.identifier.volume41en_US
dc.identifier.wosWOS:001053772003690en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofJournal of Clinical Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmz20240519_kaen_US
dc.subject[No Keywords]en_US
dc.titleCirculating tumor DNA (ctDNA) dynamics and survival outcomes in patients (pts) with advanced non-small cell lung cancer (aNSCLC) and high (>50%) programmed cell death-ligand 1 (PD-L1) expression, randomized to cemiplimab (cemi) vs chemotherapy (chemo)en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu